170 related articles for article (PubMed ID: 37643636)
21. Ovarian metastasis from uveal melanoma with MLH1/PMS2 protein loss in a patient with germline MLH1 mutated Lynch syndrome: consequence or coincidence?
Lobo J; Pinto C; Freitas M; Pinheiro M; Vizcaino R; Oliva E; Teixeira MR; Jerónimo C; Bartosch C
Virchows Arch; 2017 Mar; 470(3):347-352. PubMed ID: 27915441
[TBL] [Abstract][Full Text] [Related]
22. Constitutional MLH1 methylation presenting with colonic polyposis syndrome and not Lynch syndrome.
Kidambi TD; Blanco A; Van Ziffle J; Terdiman JP
Fam Cancer; 2016 Apr; 15(2):275-80. PubMed ID: 26781822
[TBL] [Abstract][Full Text] [Related]
23. Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome.
Dillon JL; Gonzalez JL; DeMars L; Bloch KJ; Tafe LJ
Hum Pathol; 2017 Dec; 70():121-128. PubMed ID: 29107668
[TBL] [Abstract][Full Text] [Related]
24. "Null pattern" of immunoreactivity in a Lynch syndrome-associated colon cancer due to germline MSH2 mutation and somatic MLH1 hypermethylation.
Hagen CE; Lefferts J; Hornick JL; Srivastava A
Am J Surg Pathol; 2011 Dec; 35(12):1902-5. PubMed ID: 22067334
[TBL] [Abstract][Full Text] [Related]
25. Finding the needle in a haystack: identification of cases of Lynch syndrome with MLH1 epimutation.
Hitchins MP
Fam Cancer; 2016 Jul; 15(3):413-22. PubMed ID: 26886015
[TBL] [Abstract][Full Text] [Related]
26. Targeted next generation sequencing screening of Lynch syndrome in Tunisian population.
Ben Sghaier R; Jansen AML; Bdioui A; Van Wezel T; Ksiaa M; Elgolli L; Ben Fatma L; Ben Ahmed S; Azzouz MM; Hellara O; Elghali A; Darbel F; Skandrani K; Mokkni M; Gdissa A; Ltaief R; Saad A; Hmila F; Gribaa M; Morreau H
Fam Cancer; 2019 Jul; 18(3):343-348. PubMed ID: 31114938
[TBL] [Abstract][Full Text] [Related]
27. Germline MLH1, MSH2 and MSH6 variants in Brazilian patients with colorectal cancer and clinical features suggestive of Lynch Syndrome.
Schneider NB; Pastor T; Paula AE; Achatz MI; Santos ÂRD; Vianna FSL; Rosset C; Pinheiro M; Ashton-Prolla P; Moreira MÂM; Palmero EI;
Cancer Med; 2018 May; 7(5):2078-2088. PubMed ID: 29575718
[TBL] [Abstract][Full Text] [Related]
28. Comprehensive analysis of the
Morak M; Ibisler A; Keller G; Jessen E; Laner A; Gonzales-Fassrainer D; Locher M; Massdorf T; Nissen AM; Benet-Pagès A; Holinski-Feder E
J Med Genet; 2018 Apr; 55(4):240-248. PubMed ID: 29472279
[TBL] [Abstract][Full Text] [Related]
29. MLH1 epimutation is a rare mechanism for Lynch syndrome: A case report and review of the literature.
Zyla R; Graham T; Aronson M; Velsher L; Mrkonjic M; Turashvili G
Genes Chromosomes Cancer; 2021 Sep; 60(9):635-639. PubMed ID: 33934415
[TBL] [Abstract][Full Text] [Related]
30. Rare germline mutation and MSH2-&MSH6 + expression in a double primary carcinoma of colorectal carcinoma and endometrial carcinoma: a case report.
Zhang T; Huang X; Liu W; Ling X; Su Z; Huang M; Che S
Diagn Pathol; 2024 Jan; 19(1):25. PubMed ID: 38297350
[TBL] [Abstract][Full Text] [Related]
31. [A Case of Transverse Colon Cancer Associated with Lynch Syndrome with Excellent Response to Pembrolizumab].
Mori Y; Chika N; Suzuki O; Matsuyama T; Ito T; Muta Y; Chiyonobu N; Hatano S; Momose S; Tanabe N; Akagi K; Ishida H
Gan To Kagaku Ryoho; 2023 Oct; 50(10):1111-1113. PubMed ID: 38035847
[TBL] [Abstract][Full Text] [Related]
32. Contribution of MLH1 constitutional methylation for Lynch syndrome diagnosis in patients with tumor MLH1 downregulation.
Pinto D; Pinto C; Guerra J; Pinheiro M; Santos R; Vedeld HM; Yohannes Z; Peixoto A; Santos C; Pinto P; Lopes P; Lothe R; Lind GE; Henrique R; Teixeira MR
Cancer Med; 2018 Feb; 7(2):433-444. PubMed ID: 29341452
[TBL] [Abstract][Full Text] [Related]
33. Integrating Tumor Sequencing Into Clinical Practice for Patients With Mismatch Repair-Deficient Lynch Syndrome Spectrum Cancers.
Dixon K; Asrat MJ; Bedard AC; Binnington K; Compton K; Cremin C; Heidary N; Lohn Z; Lovick N; McCullum M; Mindlin A; O'Loughlin M; Petersen T; Portigal-Todd C; Scott J; St-Martin G; Thompson J; Turnbull R; Mung SW; Hong Q; Bezeau M; Bosdet I; Tucker T; Young S; Yip S; Aubertin G; Blood KA; Nuk J; Sun S; Schrader KA
Clin Transl Gastroenterol; 2021 Aug; 12(8):e00397. PubMed ID: 34397043
[TBL] [Abstract][Full Text] [Related]
34. Advances in genetic technologies result in improved diagnosis of mismatch repair deficiency in colorectal and endometrial cancers.
Evans DG; Lalloo F; Ryan NA; Bowers N; Green K; Woodward ER; Clancy T; Bolton J; McVey RJ; Wallace AJ; Newton K; Hill J; McMahon R; Crosbie EJ
J Med Genet; 2022 Apr; 59(4):328-334. PubMed ID: 33452216
[TBL] [Abstract][Full Text] [Related]
35. Prospective determination of prevalence of lynch syndrome in young women with endometrial cancer.
Lu KH; Schorge JO; Rodabaugh KJ; Daniels MS; Sun CC; Soliman PT; White KG; Luthra R; Gershenson DM; Broaddus RR
J Clin Oncol; 2007 Nov; 25(33):5158-64. PubMed ID: 17925543
[TBL] [Abstract][Full Text] [Related]
36. MLH1 germline mutation associated with Lynch syndrome in a family followed for more than 45 years.
Momma T; Gonda K; Akama Y; Endo E; Ujiie D; Fujita S; Maejima Y; Horita S; Shimomura K; Saji S; Kono K; Yashima R; Watanabe F; Sugano K; Nomizu T
BMC Med Genet; 2019 May; 20(1):67. PubMed ID: 31046708
[TBL] [Abstract][Full Text] [Related]
37. The silent mutation MLH1 c.543C>T resulting in aberrant splicing can cause Lynch syndrome: a case report.
Yamaguchi T; Wakatsuki T; Kikuchi M; Horiguchi SI; Akagi K
Jpn J Clin Oncol; 2017 Jun; 47(6):576-580. PubMed ID: 28334867
[TBL] [Abstract][Full Text] [Related]
38. Disruption of a -35 kb Enhancer Impairs CTCF Binding and
Liu Q; Thoms JAI; Nunez AC; Huang Y; Knezevic K; Packham D; Poulos RC; Williams R; Beck D; Hawkins NJ; Ward RL; Wong JWH; Hesson LB; Sloane MA; Pimanda JE
Clin Cancer Res; 2018 Sep; 24(18):4602-4611. PubMed ID: 29898989
[No Abstract] [Full Text] [Related]
39. The spectrum of Lynch syndrome-associated germ-line mutations in Russia.
Yanus GA; Akhapkina TA; Iyevleva AG; Kornilov AV; Suspitsin EN; Kuligina ES; Ivantsov AO; Aleksakhina SN; Sokolova TN; Sokolenko AP; Togo AV; Imyanitov EN
Eur J Med Genet; 2020 Mar; 63(3):103753. PubMed ID: 31491536
[TBL] [Abstract][Full Text] [Related]
40. Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer.
Piñol V; Castells A; Andreu M; Castellví-Bel S; Alenda C; Llor X; Xicola RM; Rodríguez-Moranta F; Payá A; Jover R; Bessa X;
JAMA; 2005 Apr; 293(16):1986-94. PubMed ID: 15855432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
